Medical Editor: John P. Cunha, DO, FACOEP
Cormax (clobetasol propionate) Ointment is a synthetic corticosteroid indicated for short-term treatment of inflammatory and pruritic (itching) manifestations. Cormax Ointment should not be used in the treatment of rosacea, perioral dermatitis, acne, or as sole therapy in widespread plaque psoriasis.Cormax is available as a generic named clobetasol propionate. Common side effects of Cormax Ointment include local reactions such as burning sensations, irritation, redness, skin rash, and itching. Other side effects of Cormax Ointment include dry or cracking skin, thinning or softening of your skin, rash or irritation around your mouth, swollen hair follicles, temporary hair loss, spider veins, changes in color of treated skin, blisters, pimples, crusting of treated skin, or stretch marks.
Cormax is available in a single strength of 0.05% in 15 and 45 g tubes of ointment. Cormax Ointment is potent; therefore, treatment must be limited to two consecutive weeks, and amounts greater than 50 g per week should not be used. A thin layer of Cormax Ointment should be applied with gentle rubbing to the affected skin area twice daily, once in the morning and once at night. Occlusive dressings should not be used. No drug interactions have been reported. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are prescribed for a nursing woman. There are no adequate and well-controlled studies of the effects of Cormax Ointment on pregnant women. Cormax Ointment should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time. Cormax should not be used in pediatric patients under 12 years old.
Our Cormax Ointment Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Although the risk of serious side effects is low when clobetasol topical is applied to the skin, you should be aware of side effects that can occur if the medication is absorbed into your bloodstream.
Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing clobetasol topical through your skin, such as:
- blurred vision, or seeing halos around lights;
- mood changes;
- sleep problems (insomnia);
- weight gain, puffiness in your face; or
- muscle weakness, feeling tired.
Less serious side effects may include:
- mild skin rash, itching, burning, or redness;
- dry or cracking skin;
- thinning or softening of your skin;
- skin rash or irritation around your mouth;
- swollen hair follicles;
- temporary hair loss;
- spider veins;
- changes in color of treated skin;
- blisters, pimples, or crusting of treated skin; or
- stretch marks.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Cormax Ointment (Clobetasol Propionate Ointment)
Cormax Ointment is generally well tolerated when used for two-week treatment periods. The most frequent adverse reactions reported for clobetasol propionate ointment have been local and have included burning sensation, irritation, and itching. These occured in approximately 0.5% of the patients. Less frequent adverse reactions were stinging, cracking, erythema, folliculitis, numbness of fingers, skin atrophy, and telangiectasia, which occurred in approximately 0.3% of the patients.
The following local adverse reactions are reported infrequently when topical corticosteroids are used as recommended. These reactions are listed in an approximately decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. Systemic absorption of topical corticosteroids has produced reversible HPA axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients. In rare instances, treatment (or withdrawal of treatment) of psoriasis with corticosteroids is thought to have exacerbated the disease or provoked the pustular form of the disease, so careful patient supervision is recommended.
Read the entire FDA prescribing information for Cormax Ointment (Clobetasol Propionate Ointment)
© Cormax Ointment Patient Information is supplied by Cerner Multum, Inc. and Cormax Ointment Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.